TrialPanorama/TrialPanorama-database huggingface dataset:
Study 33996589 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 33997459 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 33997741 — Predictive Biomarker (PRD): FEV mRNA
Genes: FEV; PET1
Study 33998243 — Safety Biomarker (SAF): B-type natriuretic peptide
Genes: NPPB
Study 33998259 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 33998259 — Safety Biomarker (SAF): B-type natriuretic peptide
Genes: NPPB
Study 33998674 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 33999158 — Pharmacodynamic Biomarker (PDY): Survival motor neuron protein
Genes: SMN1; SMN; SMNT;; SMN2; SMNC
Study 33999422 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 33999653 — Surrogate Endpoint (SUR): Cervical intraepithelial neoplasia
Study 34000072 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Lactate dehydrogenase
Study 34000076 — Surrogate Endpoint (SUR): Blood pressure
Study 34000620 — Predictive Biomarker (PRD): Forkhead box protein P3
Genes: FOXP3; IPEX; JM2
Study 34000994 — Surrogate Endpoint (SUR): Blood pressure
Study 34001647 — Predictive Biomarker (PRD): CAPS mRNA
Genes: CAPS
Study 34001692 — Predictive Biomarker (PRD): IL17F
Genes: IL-17F; ML-1; ML1
Study 34001692 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Interleukin 17
Genes: IL17A; CTLA8; IL17
Study 34001758 — Surrogate Endpoint (SUR): Blood pressure
Study 34003074 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 34003409 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Cellular tumor antigen p53
Genes: TP53; P53
Study 34003409 — Predictive Biomarker (PRD): PIK3CA mRNA
Genes: PIK3CA
Study 34003409 — Monitoring Biomarker (MOI): Circulating tumor DNA
Study 34004576 — Predictive Biomarker (PRD): MSC mRNA
Genes: MSC; ABF1; BHLHA22
Study 34006291 — Predictive Biomarker (PRD): PIK3CA mRNA
Genes: PIK3CA
Study 34006291 — Predictive Biomarker (PRD): KRAS mRNA
Genes: KRAS; KRAS2; RASK2
Study 34006291 — Predictive Biomarker (PRD): Phosphatase and tensin homolog
Genes: PTEN; MMAC1; TEP1
Study 34006291 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 34006291 — Predictive Biomarker (PRD): BRCA1 mRNA
Genes: BRCA1; RNF53
Study 34006291 — Predictive Biomarker (PRD): Homologous recombination deficiency
Study 34006291 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Tumor mutational burden
Study 34006499 — Monitoring Biomarker (MOI): Circulating tumor DNA
Study 34007002 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Growth/differentiation factor 15
Genes: GDF15; MIC1; PDF; PLAB; PTGFB
Study 34007002 — Predictive Biomarker (PRD): FGF21 mRNA
Genes: FGF21; UNQ3115/PRO10196
Study 34007050 — Pharmacodynamic Biomarker (PDY): Interleukin 7 receptor alpha
Genes: IL7R
Study 34007050 — Predictive Biomarker (PRD): Apoptosis regulator Bcl-2
Genes: BCL2
Study 34007050 — Predictive Biomarker (PRD): Induced myeloid leukemia cell differentiation protein Mcl-1
Genes: MCL1; BCL2L3
Study 34007050 — Predictive Biomarker (PRD): JAK1 mRNA
Genes: JAK1; JAK1A; JAK1B
Study 34007803 — Predictive Biomarker (PRD): SCT mRNA
Genes: SCT
Study 34007845 — Predictive Biomarker (PRD): SCT mRNA
Genes: SCT
Study 34008163 — Predictive Biomarker (PRD): DEGS1 mRNA
Genes: DEGS1; DES1; MLD; MIG15
Study 34011535 — Predictive Biomarker (PRD): GCNT2 mRNA
Genes: GCNT2; GCNT5; II; NACGT1
Study 34011535 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study 34011535 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Tumor mutational burden
Study 34011995 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 34012367 — Predictive Biomarker (PRD); Safety Biomarker (SAF): PIK3CA
Genes: PI3K
Study 34012367 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 34012920 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor receptor 2
Genes: KDR; FLK1; VEGFR2
Study 34012920 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study 34013092 — Safety Biomarker (SAF): Cardiac troponin I
Genes: TNNI3; TNNC1
Study 34013182 — Predictive Biomarker (PRD): VCX mRNA
Genes: VCX; VCX1; VCX10R; VCXB1
Study 34014429 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 34014839 — Predictive Biomarker (PRD): SPTA1 mRNA
Genes: SPTA1; SPTA
Study 34014839 — Predictive Biomarker (PRD): ALDH2 mRNA
Genes: ALDH2; ALDM
Study 34014839 — Predictive Biomarker (PRD): ANK1 mRNA
Genes: ANK1; ANK
Study 34014839 — Predictive Biomarker (PRD): AQP1 mRNA
Genes: AQP1; CHIP28
Study 34014839 — Predictive Biomarker (PRD): GLRX mRNA
Genes: GLRX; GRX
Study 34014839 — Predictive Biomarker (PRD): GPX4 mRNA
Genes: GPX4
Study 34014839 — Safety Biomarker (SAF): Glucose-6-phosphate dehydrogenase
Genes: G6PD
Study 34014839 — Predictive Biomarker (PRD): SEC14L4 mRNA
Genes: SEC14L4; TAP3
Study 34014839 — Predictive Biomarker (PRD): HBA1 mRNA
Genes: HBA1; HBA2
Study 34016182 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Cellular tumor antigen p53
Genes: TP53; P53
Study 34016182 — Predictive Biomarker (PRD): PIK3CA mRNA
Genes: PIK3CA
Study 34016182 — Predictive Biomarker (PRD): CDK4 mRNA
Genes: CDK4
Study 34016182 — Predictive Biomarker (PRD): Phosphatase and tensin homolog
Genes: PTEN; MMAC1; TEP1
Study 34016182 — Monitoring Biomarker (MOI): Circulating tumor DNA
Study 34016561 — Predictive Biomarker (PRD): MIF mRNA
Genes: MIF; GLIF; MMIF
Study 34016877 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 34016879 — Predictive Biomarker (PRD): ATP8B1 mRNA
Genes: ATP8B1; ATPIC; FIC1; PFIC
Study 34016879 — Predictive Biomarker (PRD): ABCB4 mRNA
Genes: ABCB4; MDR3; PGY3
Study 34017073 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study 34017617 — Predictive Biomarker (PRD): MAP3K10 mRNA
Genes: MAP3K10; MLK2; MST
Study 34017617 — Predictive Biomarker (PRD): HMBS mRNA
Genes: HMBS; PBGD; UPS
Study 34017617 — Predictive Biomarker (PRD): DMD
Genes: BMD; DXS142; DXS164; DXS206; DXS230; DXS239; DXS268; DXS269; DXS270; DXS272
Study 34018141 — Monitoring Biomarker (MOI): Procalcitonin
Study 34018141 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 34019108 — Predictive Biomarker (PRD): CYP3A4 mRNA
Genes: CYP3A4; CYP3A3
Study 34019108 — Predictive Biomarker (PRD): JAK2
Genes: JTK10
Study 34019698 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study 34020658 — Predictive Biomarker (PRD): Exhaled nitric oxide
Study 34020658 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Immunoglobulin E
Study 34021827 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study 34022380 — Predictive Biomarker (PRD): CTAG1B mRNA
Genes: CTAG1A; CTAG; CTAG1; ESO1; LAGE2; LAGE2A; CTAG1B; LAGE2B
Study 34022698 — Predictive Biomarker (PRD): CD244 mRNA
Genes: CD244; 2B4
Study 34022698 — Predictive Biomarker (PRD): FCGR3B
Genes: CD16; CD16b; FcgammaRIIIb; FcRIIIb
Study 34022795 — Predictive Biomarker (PRD): GAD1 mRNA
Genes: GAD1; GAD; GAD67
Study 34022802 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 34022805 — Surrogate Endpoint (SUR): Blood pressure
Study 34024024 — Predictive Biomarker (PRD): TTR mRNA
Genes: TTR; PALB
Study 34025640 — Predictive Biomarker (PRD): CD68 mRNA
Genes: CD68
Study 34025651 — Predictive Biomarker (PRD): CFTR mRNA
Genes: CFTR; ABCC7
Study 34025651 — Predictive Biomarker (PRD): CFTR
Genes: MRP7; ABC35; TNR-CFTR; dJ760C5.1; CFTR/MRP
Study 34025681 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study 34025681 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study 34025756 — Predictive Biomarker (PRD): GAD1 mRNA
Genes: GAD1; GAD; GAD67
Study 34026647 — Predictive Biomarker (PRD): IDH1 mRNA
Genes: IDH1; PICD
Study 34026647 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study 34026784 — Predictive Biomarker (PRD): TNFRSF17 mRNA
Genes: TNFRSF17; BCM; BCMA
Study 34026784 — Predictive Biomarker (PRD): CD38 mRNA
Genes: CD38
Study 34027894 — Surrogate Endpoint (SUR): Blood pressure
Study 34028627 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study 34028627 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Angiopoietin-2
Genes: ANGPT2
Study 34028701 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Neutrophil gelatinase-associated lipocalin
Genes: LCN2; HNL; NGAL
Study 34028812 — Surrogate Endpoint (SUR): Blood pressure
Study 34029273 — Predictive Biomarker (PRD): MAX mRNA
Genes: MAX; BHLHD4
Study 34029566 — Predictive Biomarker (PRD): FEV mRNA
Genes: FEV; PET1
Study 34029566 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 34030643 — Predictive Biomarker (PRD): BRCA1 mRNA
Genes: BRCA1; RNF53
Study 34030643 — Predictive Biomarker (PRD): BRCA2 mRNA
Genes: BRCA2; FACD; FANCD1
Study 34030643 — Predictive Biomarker (PRD): Homologous recombination deficiency
Study 34030728 — Surrogate Endpoint (SUR): Serum creatinine
Study 34031519 — Predictive Biomarker (PRD): Apolipoprotein E
Genes: APOE
Study 34031519 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study 34031519 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 34032893 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study 34032932 — Surrogate Endpoint (SUR): Blood pressure
Study 34034772 — Predictive Biomarker (PRD): TF mRNA
Genes: TF; PRO1400
Study 34034777 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study 34034795 — Predictive Biomarker (PRD): CD38 mRNA
Genes: CD38
Study 34035077 — Surrogate Endpoint (SUR): Blood pressure
Study 34035097 — Surrogate Endpoint (SUR): Blood pressure
Study 34035103 — Predictive Biomarker (PRD): MCIDAS mRNA
Genes: MCIDAS; IDAS; MCI; MCIN
Study 34035477 — Predictive Biomarker (PRD): NUCB1 mRNA
Genes: NUCB1; NUC
Study 34035477 — Predictive Biomarker (PRD): DST mRNA
Genes: DST; BP230; BP240; BPAG1; DMH; DT; KIAA0728
Study 34035477 — Predictive Biomarker (PRD): GCC2 mRNA
Genes: GCC2; KIAA0336; RANBP2L4
Study 34036343 — Predictive Biomarker (PRD): CCK mRNA
Genes: CCK
Study 34037241 — Predictive Biomarker (PRD): Hormone receptor
Study 34038556 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 34038589 — Predictive Biomarker (PRD); Safety Biomarker (SAF): CTNNB1 mRNA
Genes: CTNNB1; CTNNB; OK/SW-cl.35; PRO2286
Study 34039015 — Surrogate Endpoint (SUR): Blood pressure
Study 34039285 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 34039285 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 34039647 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Tumor mutational burden
Study 34040174 — Predictive Biomarker (PRD): ANTXR1 mRNA
Genes: ANTXR1; ATR; TEM8
Study 34040175 — Predictive Biomarker (PRD): ANTXR1 mRNA
Genes: ANTXR1; ATR; TEM8
Study 34040195 — Predictive Biomarker (PRD): IGFBP7 mRNA
Genes: IGFBP7; MAC25; PSF
Study 34040195 — Predictive Biomarker (PRD): IGF1 mRNA
Genes: IGF1; IBP1
Study 34040605 — Predictive Biomarker (PRD): NAGLU mRNA
Genes: NAGLU; UFHSD1
Study 34040605 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 34041648 — Surrogate Endpoint (SUR): Blood pressure
Study 34043668 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 34043668 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Serum albumin
Genes: ALB; GIG20; GIG42; PRO0903; PRO1708; PRO2044; PRO2619; PRO2675; UNQ696/PRO1341
Study 34043812 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study 34044190 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 34044190 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 34045234 — Predictive Biomarker (PRD): PSMB8 mRNA
Genes: PSMB8; LMP7; PSMB5i; RING10; Y2
Study 34046035 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study 34047953 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 34047953 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 34047959 — Surrogate Endpoint (SUR): Blood pressure
Study 34047959 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 34048072 — Predictive Biomarker (PRD): AFF1 mRNA
Genes: AFF1; AF4; FEL; MLLT2; PBM1
Study 34048072 — Pharmacodynamic Biomarker (PDY): Tyrosine-protein kinase ABL1
Genes: ABL1; ABL; JTK7
Study 34048282 — Predictive Biomarker (PRD): DMD mRNA
Genes: DMD
Study 34048509 — Predictive Biomarker (PRD): STS mRNA
Genes: STS; ARSC1
Study 34048594 — Monitoring Biomarker (MOI): HBV DNA
Study 34049308 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Angiopoietin-2
Genes: ANGPT2
Study 34049308 — Safety Biomarker (SAF): von Willebrand factor
Genes: VWF; F8VWF
Study 34049308 — Monitoring Biomarker (MOI): Angiopoietin-1
Genes: ANGPT1; KIAA0003
Study 34049362 — Predictive Biomarker (PRD): CD34 mRNA
Genes: CD34
Study 34049394 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY): Platelet glycoprotein 4
Genes: CD36; GP3B; GP4
Study 34049394 — Predictive Biomarker (PRD): BCO1 mRNA
Genes: BCO1; BCDO; BCDO1; BCMO1
Study 34049582 — Predictive Biomarker (PRD): SCT mRNA
Genes: SCT
Study 34050156 — Monitoring Biomarker (MOI): Cell-free DNA
Study 34050156 — Monitoring Biomarker (MOI): Circulating tumor DNA
Study 34050237 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Lactate dehydrogenase
Study 34050260 — Predictive Biomarker (PRD): CD38 mRNA
Genes: CD38
Study 34051936 — Surrogate Endpoint (SUR): Blood pressure
Study 34052705 — Predictive Biomarker (PRD): KRAS mRNA
Genes: KRAS; KRAS2; RASK2
Study 34052705 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study 34052705 — Predictive Biomarker (PRD): NRAS mRNA
Genes: NRAS; HRAS1
Study 34052705 — Predictive Biomarker (PRD): MAP2K1 mRNA
Genes: MAP2K1; MEK1; PRKMK1
Study 34053700 — Predictive Biomarker (PRD): Proto-oncogene c-Met
Genes: MET
Study 34055403 — Surrogate Endpoint (SUR): Blood pressure
Study 34056687 — Predictive Biomarker (PRD): Aurora kinase A
Genes: AURKA; AIK; AIRK1; ARK1; AURA; AYK1; BTAK; IAK1; STK15; STK6
Study 34056870 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 34057232 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study 34058148 — Predictive Biomarker (PRD); Safety Biomarker (SAF): MUC5AC mRNA
Genes: MUC5AC; MUC5
Study 34058148 — Predictive Biomarker (PRD): MUC5B mRNA
Genes: MUC5B; MUC5
Study 34058888 — Surrogate Endpoint (SUR): Blood pressure
Study 34059525 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 34059639 — Predictive Biomarker (PRD): CPOX mRNA
Genes: CPOX; CPO; CPX
Study 34059991 — Monitoring Biomarker (MOI): HBV DNA
Study 34060012 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Interleukin 17
Genes: IL17A; CTLA8; IL17
Study 34060483 — Predictive Biomarker (PRD): ACVR2A mRNA
Genes: ACVR2A; ACVR2
Study 34065252 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study 34065642 — Predictive Biomarker (PRD): SERPINA5 mRNA
Genes: SERPINA5; PCI; PLANH3; PROCI
Study 34065859 — Predictive Biomarker (PRD): PMAIP1 mRNA
Genes: PMAIP1; NOXA
Study 34065859 — Predictive Biomarker (PRD): SS18 mRNA
Genes: SS18; SSXT; SYT
Study 34065859 — Predictive Biomarker (PRD): CLEC4D mRNA
Genes: CLEC4D; CLECSF8; MCL
Study 34066473 — Predictive Biomarker (PRD): ASRGL1 mRNA
Genes: ASRGL1; ALP; CRASH
Study 34066713 — Predictive Biomarker (PRD): CD34 mRNA
Genes: CD34
Study 34067093 — Predictive Biomarker (PRD): UCP1 mRNA
Genes: UCP1; SLC25A7; UCP
Study 34069594 — Predictive Biomarker (PRD): AFP mRNA
Genes: AFP; HPAFP
Study 34070044 — Predictive Biomarker (PRD): LAG3 mRNA
Genes: LAG3; FDC
Study 34071188 — Predictive Biomarker (PRD): APC mRNA
Genes: APC; DP2.5
Study 34072165 — Predictive Biomarker (PRD): CS mRNA
Genes: CS
Study 34074889 — Predictive Biomarker (PRD): SLC5A2 mRNA
Genes: SLC5A2; SGLT2
Study 34076745 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study 34076831 — Predictive Biomarker (PRD): MYC mRNA
Genes: MYC; BHLHE39
Study 34077628 — Predictive Biomarker (PRD): GGT1 mRNA
Genes: GGT1; GGT
Study 34078022 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 34078399 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): D-dimer
Study 34078399 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 34078435 — Predictive Biomarker (PRD): GFAP mRNA
Genes: GFAP
Study 34078652 — Predictive Biomarker (PRD): IDH1 mRNA
Genes: IDH1; PICD
Study 34080309 — Predictive Biomarker (PRD): MDM2 mRNA
Genes: MDM2
Study 34080441 — Predictive Biomarker (PRD): SCD mRNA
Genes: SCD; FADS5; SCD1; SCDOS
Study 34081015 — Surrogate Endpoint (SUR): Blood pressure
Study 34082024 — Predictive Biomarker (PRD): CXCR2 mRNA
Genes: CXCR2; IL8RB
Study 34082024 — Predictive Biomarker (PRD): CXCR4 mRNA
Genes: CXCR4
Study 34083232 — Predictive Biomarker (PRD): PTK7 mRNA
Genes: PTK7; CCK4
Study 34083421 — Safety Biomarker (SAF): PDCD1
Genes: CD279; PD1; hSLE1; PD-1
Study 34083737 — Predictive Biomarker (PRD): SPINK1 mRNA
Genes: SPINK1; PSTI
Study 34083737 — Predictive Biomarker (PRD): CRYBB2 mRNA
Genes: CRYBB2; CRYB2; CRYB2A
Study 34083737 — Predictive Biomarker (PRD): GSTM3 mRNA
Genes: GSTM3; GST5
Study 34083737 — Predictive Biomarker (PRD): IL33 mRNA
Genes: IL33; C9orf26; IL1F11; NFHEV
Study 34083737 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Interferon gamma
Genes: IFNG
Study 34083737 — Monitoring Biomarker (MOI): C-C motif chemokine 4
Genes: CCL4; LAG1; MIP1B; SCYA4
Study 34083737 — Predictive Biomarker (PRD): ICOSLG mRNA
Genes: ICOSLG; B7H2; B7RP1; ICOSL; KIAA0653
Study 34083737 — Predictive Biomarker (PRD): DNA mismatch repair protein MSH2
Genes: MSH2
Study 34083737 — Safety Biomarker (SAF): Reactive oxygen species
Study 34084608 — Predictive Biomarker (PRD): ZMYM2 mRNA
Genes: ZMYM2; FIM; RAMP; ZNF198
Study 34084993 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 34085949 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 34086171 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 34086266 — Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): TNF related activation protein
Genes: CD40LG; CD40L; TNFSF5; TRAP
Study 34086266 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): D-dimer
Study 34086266 — Safety Biomarker (SAF): Plasminogen activator inhibitor
Genes: SERPINE1; PAI1; PLANH1
Study 34086865 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Cellular tumor antigen p53
Genes: TP53; P53
Study 34087573 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 34087573 — Predictive Biomarker (PRD): Hormone receptor
Study 34087863 — Surrogate Endpoint (SUR): Blood pressure
Study 34088726 — Predictive Biomarker (PRD): RET mRNA
Genes: RET; CDHF12; CDHR16; PTC; RET51
Study 34088741 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 34089087 — Predictive Biomarker (PRD): Proto-oncogene c-Met
Genes: MET
Study 34089650 — Pharmacodynamic Biomarker (PDY): Survival motor neuron protein
Genes: SMN1; SMN; SMNT;; SMN2; SMNC
Study 34090143 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 34090143 — Predictive Biomarker (PRD): Hormone receptor
Study 34090871 — Surrogate Endpoint (SUR): Pulmonary vascular resistance
Study 34091914 — Surrogate Endpoint (SUR): Pathological complete response
Study 34092233 — Predictive Biomarker (PRD): CD40 mRNA
Genes: CD40; TNFRSF5
Study 34092233 — Predictive Biomarker (PRD): PITX2 mRNA
Genes: PITX2; ARP1; RGS; RIEG; RIEG1
Study 34094549 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study 34096690 — Predictive Biomarker (PRD): Programmed cell death 1 ligand 1
Genes: CD274; B7H1; PDCD1L1; PDCD1LG1; PDL1
Study 34096690 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Tumor mutational burden
Study 34096876 — Predictive Biomarker (PRD): PAH mRNA
Genes: PAH
Study 34096986 — Predictive Biomarker (PRD): SMPD1 mRNA
Genes: SMPD1; ASM
Study 34097071 — Predictive Biomarker (PRD): POMC
Genes: MSH; POC; CLIP; ACTH; NPP; LPH
Study 34097071 — Predictive Biomarker (PRD): CRH mRNA
Genes: CRH
Study 34097100 — Predictive Biomarker (PRD): TPI1 mRNA
Genes: TPI1; TPI
Study 34097852 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study 34099056 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study 34099718 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 34099953 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 34100124 — Predictive Biomarker (PRD); Safety Biomarker (SAF): MHC class I polypeptide-related sequence A
Genes: MICA; PERB11.1
Study 34100124 — Predictive Biomarker (PRD): BCAM mRNA
Genes: BCAM; LU; MSK19
Study 34101002 — Surrogate Endpoint (SUR): Blood pressure
Study 34101002 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Serum albumin
Genes: ALB; GIG20; GIG42; PRO0903; PRO1708; PRO2044; PRO2619; PRO2675; UNQ696/PRO1341
Study 34101626 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 34103352 — Predictive Biomarker (PRD): Programmed cell death 1 ligand 1
Genes: CD274; B7H1; PDCD1L1; PDCD1LG1; PDL1
Study 34106085 — Surrogate Endpoint (SUR): Blood pressure
Study 34106597 — Predictive Biomarker (PRD): KLHL17 mRNA
Genes: KLHL17; AF
Study 34107166 — Safety Biomarker (SAF): Cytochrome P450 2C19
Genes: CYP2C19
Study 34107166 — Predictive Biomarker (PRD): CYP1A2 mRNA
Genes: CYP1A2
Study 34107166 — Predictive Biomarker (PRD): CYP2C9 mRNA
Genes: CYP2C9; CYP2C10
Study 34107166 — Predictive Biomarker (PRD): CYP2B6 mRNA
Genes: CYP2B6
Study 34107166 — Safety Biomarker (SAF): Cytochrome P450 2D6
Genes: CYP2D6; CYP2DL1
Study 34107166 — Safety Biomarker (SAF): Reactive oxygen species
Study 34107398 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY): Microtubule-associated protein tau
Genes: MAPT; MAPTL; MTBT1; TAU